Sun Pharma Dermatology is a large pharma headquartered in India. Over the past three years, Sun Pharma Dermatology has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (1 deal).
Deals (12mo)
0
Active Trials
10
Top Modality
Small Molecules
Focus Area
Dermatology
Therapeutic areas and modalities where Sun Pharma Dermatology is most active based on deal history and clinical trial data.
Key indicators of Sun Pharma Dermatology's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Acquisition Appetite
Strategic Priorities
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
Sun Pharma Dermatology is a large pharma company based in India that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Sun Pharma Dermatology ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sun Pharma Dermatology include Dermatology (1 deal and trial). In terms of modality, Sun Pharma Dermatology has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sun Pharma Dermatology and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sun Pharma Dermatology's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.
© 2026 Ambrosia Ventures. All rights reserved.
Benchmarks powered by 3,000+ real biopharma licensing deals